Study: NCT04091971

Adverse event: Insomnia
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Nightmare
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Somnolence
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Feeling nervous or hyper
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Irritability
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Memory difficulties
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Trouble concentrating
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Ringing in Ears or Trouble Hearing
Serious: no
Organ System: Ear and labyrinth disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Drooling or Increased Salivation
Serious: no
Organ System: General disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Heartbeat rapid or pounding
Serious: no
Organ System: Cardiac disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Trouble catching breath or hyperventilation
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Chest pain
Serious: no
Organ System: Cardiac disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Nausea or vomiting
Serious: no
Organ System: Gastrointestinal disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Frequent need to urinate
Serious: no
Organ System: Renal and urinary disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk

Adverse event: Loss of Sexual Interest
Serious: no
Organ System: Reproductive system and breast disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Delayed or absent orgasm
Serious: no
Organ System: Reproductive system and breast disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Excessive Sweating
Serious: no
Organ System: General disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 3 affected / 9 at risk

Adverse event: Decreased appetite
Serious: no
Organ System: Gastrointestinal disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 3 affected / 9 at risk

Adverse event: Increased appetite
Serious: no
Organ System: Gastrointestinal disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Weight decreased
Serious: no
Organ System: General disorders
Frequency: 1 affected / 9 at risk

Adverse event: Skin rash or allergy
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Word finding difficulties
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Apathy/emotional indifference
Serious: no
Organ System: Nervous system disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 1 affected / 9 at risk

Adverse event: Hair thinning/loss
Serious: no
Organ System: General disorders
Notes: Assessed by SAFTEE self-report at 8 time points after commencing ketamine. All items endorsed that were not present at at least the same level pre-ketamine assessed via SAFTEE are included in this table, whether related to study procedures or not.
Frequency: 2 affected / 9 at risk